hepatic glutathione alcohol Advances in identifying risk factors of metabolic dysfunction-associated alcohol-related liver disease Glutathione S-transferase Mu 3 Mitigates

Retatrutide appears to produce the fastest weight loss trajectory, with participants in Phase 2 trials losing 24.2% of body weight in just 48 weeks, a pace that outstrips semaglutide and tirzepatide over comparable timeframes

& Guttmann, A

It is encouraging that the persister drug combination approach, developed per the Yin-Yang model based on the persister drug PZA, has produced promising results to more effectively kill persisters and biofilm bacteria not only in vitro but also cure the persistent infections in animal models in vivo

PD-induced mice model was treated with BV2-metformin-loaded PLGA 3 times per week for 34 weeks

Kim, J.H